Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet F. Eary

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcomeAlexander M Spence, Mark Muzi, Michael M Graham, et al.
Nuclear Medicine and Biology|October 9, 2007
Challenges in clinical studies with multiple imaging probesKenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphomaAjay K Gopal, Joseph G Rajendran, Ted A Gooley, et al.
Plos One|March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabineSeth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
Molecular Imaging and Biology|October 17, 2018
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Molecular Imaging and Biology|October 31, 2013
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC)Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Cancer|February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaSeth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 18, 2002
Detection of locoregional and distant recurrences in breast cancer patients by using FDG PETWilliam B Eubank, David A Mankoff, Hubert J Vesselle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer DiseaseAnand K Deo, Soo Borson, Jeanne M Link, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 4, 2006
166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapyHazel B Breitz, Richard E Wendt, Michael S Stabin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
2-[(18)F]Fluoro-2-deoxyglucose and glucose uptake in malignant gliomas before and after radiotherapy: correlation with outcomeAlexander M Spence, Mark Muzi, Michael M Graham, et al.
Nuclear Medicine and Biology|October 9, 2007
Challenges in clinical studies with multiple imaging probesKenneth A Krohn, Finbarr O'Sullivan, John Crowley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2007
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphomaAjay K Gopal, Joseph G Rajendran, Ted A Gooley, et al.
Plos One|March 3, 2012
NYESO-1/LAGE-1s and PRAME are targets for antigen specific T cells in chondrosarcoma following treatment with 5-Aza-2-deoxycitabineSeth M Pollack, Yonqing Li, Megan J Blaisdell, et al.
Molecular Imaging and Biology|October 17, 2018
Correction to: a Phase 2 Study of 16α-[18F]-Fluoro-17β-Estradiol Positron Emission Tomography (FES-PET) as a Marker of Hormone Sensitivity in Metastatic Breast Cancer (MBC)Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Molecular Imaging and Biology|October 31, 2013
A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC)Lanell M Peterson, Brenda F Kurland, Erin K Schubert, et al.
Cancer|February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaSeth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 18, 2002
Detection of locoregional and distant recurrences in breast cancer patients by using FDG PETWilliam B Eubank, David A Mankoff, Hubert J Vesselle, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2014
Activity of P-Glycoprotein, a β-Amyloid Transporter at the Blood-Brain Barrier, Is Compromised in Patients with Mild Alzheimer DiseaseAnand K Deo, Soo Borson, Jeanne M Link, et al.
Pageof 7